Recode Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- November 18, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $15,000,000
Company Info
- Organizations Involved
- The Cystic Fibrosis Foundation
- Company Description
- Recode Therapeutics is focused on developing a gene editing therapy that could be delivered into the lung cells of people with cystic fibrosis.
- Market
- Cystic Fibrosis
- Location
- Menlo Park, California, USA
- Coinvestors
- The Cystic Fibrosis Foundation